Mental and behavioural disorders due to cannabinoids

F5_CANNABIS

cannabis dependence: Physical and psychological dependence on the drug cannabis.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F12 Hospital discharge: ICD-9 — 3052\|3043 Hospital discharge: ICD-8 — 3045 Cause of death: ICD-10 — F12 Cause of death: ICD-9 — 3052\|3043 Cause of death: ICD-8 — 3045 2 out of 7 registries used, show all original rules.	1262
4. Check minimum number of events None	1262
5. Include endpoints None	1262
6. Filter based on genotype QC (FinnGen only)	1262

Control definitions (FinnGen only)

Control exclude: F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F10-F19
Name in latin: Perturbationes mentis et modi se gerendi ex usu cannabinoidum

NAME	F5_CANNABIS
CONTROL_EXCLUDE	F5_SUBSNOALCO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F12
HD_ICD_9	3052\|3043
HD_ICD_8	3045
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F12
COD_ICD_9	3052\|3043
COD_ICD_8	3045
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders due to cannabinoids based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16485	3931	12473
Only index persons	15328	3776	11552
Unadjusted period prevalence (%)
Whole population	0.29	0.11	0.35
Only index persons	0.37	0.14	0.44
Median age at first event (years)
Whole population	23.76	22.13	24.23
Only index persons	23.61	22.05	24.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1262	399	863
Unadjusted period prevalence (%)	0.30	0.14	0.38
Median age at first event (years)	25.27	24.42	25.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1172: Matched controls
11717

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AH04

ATC

quetiapine; oral

17.0

323.0

794

1287

F29

ICD-10 Finland

Unspecified nonorganic psychosis

32.3

323.0

583

348

B18.2

ICD-10 Finland

Chronic viral hepatitis C

203.2

323.0

345

N05AH03

ATC

olanzapine; systemic

30.2

323.0

617

416

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

1333.6

323.0

523

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

24.5

323.0

618

511

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

803.6

320.1

301

P19

ICPC

Drug abuse

103.5

285.8

307

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

18.4

266.8

443

374

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

+∞

266.0

245

T36

ICD-10 Finland

Poisoning by systemic antibiotics

23.6

260.5

389

241

N05AX08

ATC

risperidone; systemic

16.9

253.5

437

399

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

710.4

241.1

230

N05BA01

ATC

diazepam; systemic, rectal

13.3

224.8

434

496

N05AX12

ATC

aripiprazole; systemic

15.2

218.2

390

372

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

22.7

214.0

321

191

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

2582.1

212.0

199

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

+∞

209.9

195

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.4

196.6

523

1028

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

2327.9

196.5

185

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

12.7

193.1

375

417

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

2240.4

191.0

180

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

1066.8

190.1

181

N05BA04

ATC

oxazepam; oral

7.5

189.8

566

1305

N05AA02

ATC

levomepromazine; systemic

28.9

187.3

259

114

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

2004.1

175.5

166

N03AG01

ATC

valproic acid; systemic, rectal

12.5

171.4

332

358

Z2446

NOMESCO Finland

Social worker

12.5

166.2

321

342

Z72.2

ICD-10 Finland

Drug use

115.7

165.4

177

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

30.3

165.4

225

N07BB01

ATC

disulfiram; oral

16.2

164.0

279

222

N06AX11

ATC

mirtazapine; oral

5.8

162.0

628

1934

F12.5

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, psychotic disorder

+∞

159.1

149

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.3

152.6

431

866

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

+∞

150.3

141

N05CD07

ATC

temazepam; oral

18.4

148.4

238

160

N05AH02

ATC

clozapine; systemic

19.3

147.4

232

148

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

1596.6

147.1

140

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

+∞

147.0

138

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

33.4

146.7

194

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

19.7

137.4

214

131

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

1459.2

136.2

130

N03AE01

ATC

clonazepam; systemic

16.3

135.6

228

171

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

1421.4

133.0

127

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

+∞

130.7

123

ZY000

NOMESCO Finland

Hospital inpatient

30.0

130.2

177

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

+∞

128.5

121

N06AB04

ATC

citalopram; systemic

5.8

127.5

437

1088

N06AX16

ATC

venlafaxine; oral

6.2

127.1

405

921

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

1334.0

125.4

120

N06AB03

ATC

fluoxetine; oral

7.7

123.5

319

540

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.2

123.3

387

858

F20.9

ICD-10 Finland

Schizophrenia, unspecified

17.5

123.0

200

136

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

659.0

122.6

119

ZY010

NOMESCO Finland

Hospital outpatient

9.4

122.0

273

366

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

13.6

121.5

221

197

N05BA12

ATC

alprazolam; oral

9.3

120.7

273

372

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

13.6

119.6

217

192

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.6

118.6

208

170

N05AF03

ATC

chlorprothixene; systemic

23.4

118.3

173

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

57.8

117.2

138

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

1235.6

116.8

112

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

+∞

115.6

109

Z3231

NOMESCO Finland

Registered nurse

4.8

115.2

490

1520

C07AA05

ATC

propranolol; systemic

5.2

113.0

433

1196

N05CF01

ATC

zopiclone; oral

5.0

110.5

443

1279

F10.20

ICD-10 Finland

Alcohol dependence currently independent

27.6

108.0

150

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

567.3

106.5

104

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

12.7

106.1

198

184

P29

ICPC

Psychological sympt/compl other

7.4

105.8

278

472

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

9.4

102.9

228

294

N05AD01

ATC

haloperidol; systemic

22.5

102.9

152

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

18.7

101.5

160

N05AB03

ATC

perphenazine; systemic, rectal

15.9

100.9

170

124

P15

ICPC

Chronic alcohol abuse

14.8

98.5

171

134

N06AB06

ATC

sertraline; oral

5.6

94.8

317

728

P18

ICPC

Medication abuse

81.2

93.0

104

F10.25

ICD-10 Finland

Alcohol dependence continuous use

27.2

92.7

129

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

7.5

91.9

235

377

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.0

91.5

249

437

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

9.6

91.1

198

244

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

+∞

90.8

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

12.9

90.6

167

149

F60.9

ICD-10 Finland

Personality disorder, unspecified

21.8

89.9

134

N03AX09

ATC

lamotrigine; oral

7.9

89.4

220

332

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

127.6

88.4

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

15.8

88.2

148

106

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

21.9

88.1

131

N06AB10

ATC

escitalopram; oral

3.9

87.8

468

1699

F60.2

ICD-10 Finland

Dissocial personality disorder

113.4

87.3

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

8.1

87.2

210

306

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

14.7

87.1

151

117

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

8.2

84.5

202

290

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

9.5

84.4

183

223

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

24.0

83.8

121

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

+∞

82.3

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

+∞

82.3

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.9

81.8

309

798

N05AN01

ATC

lithium; oral

14.1

81.8

144

115

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

10.5

81.8

167

182

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

23.3

81.1

118

SPAT1272

SPAT

Drug screening

54.9

80.9

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

28.4

80.9

111

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

8.1

80.2

193

279

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

420.0

79.9

F12.9

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, unspecified mental and behavioural disorder

+∞

78.0

P72

ICPC

Schizophrenia

14.5

77.8

135

104

N05BE01

ATC

buspirone; oral

15.6

77.2

130

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

21.3

76.1

114

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

+∞

75.9

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

397.0

75.7

F10.24

ICD-10 Finland

Alcohol depence active use

21.1

75.2

113

F12.26

ICD-10 Finland

Addiction caused by cannabis intermittent drug addiction

+∞

74.8

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

14.3

74.6

130

101

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

164.6

73.9

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

741.9

71.9

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

11.3

71.6

140

139

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

+∞

69.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

10.4

69.1

141

152

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

27.8

69.0

N04AA02

ATC

biperiden; systemic

18.5

68.8

108

Z2445

NOMESCO Finland

Psychologist

7.3

67.6

173

271

F61.0

ICD-10 Finland

Mixed personality disorders

13.9

66.3

117

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

7.4

65.3

166

257

N06AX12

ATC

bupropion; oral

5.1

64.9

228

532

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

+∞

64.1

P99

ICPC

Psychological disorders other

8.1

63.5

151

211

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

+∞

63.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.4

62.6

178

321

IGV01

NOMESCO Finland

Psychiatric network contact

19.6

62.6

N05BA02

ATC

chlordiazepoxide; systemic

23.7

62.4

N05BA06

ATC

lorazepam; systemic, sublingual

9.8

62.4

131

148

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

+∞

62.0

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

62.0

K04.5

ICD-10 Finland

Chronic apical periodontitis

3.4

61.9

372

1408

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

25.3

61.6

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

14.3

61.5

107

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.2

61.3

144

197

Z2221

NOMESCO Finland

Medical doctor

3.2

61.3

404

1635

N05AA01

ATC

chlorpromazine; systemic, rectal

26.8

61.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.4

60.2

244

656

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

9.4

60.0

129

152

SPAT1265

SPAT

Breathalyser

19.6

59.4

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

14.1

57.9

101

ZXY49

NOMESCO Finland

Other health care provider

25.5

57.5

N05AF05

ATC

zuclopenthixol; systemic

30.7

56.1

A46

ICD-10 Finland

Erysipelas

5.0

55.4

193

441

SPAT1227

SPAT

Substance abuse rehabilitation

39.1

55.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.9

55.0

196

459

N05CF02

ATC

zolpidem; oral

3.8

54.9

268

848

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.9

54.3

113

125

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

21.1

54.3

T74.1

ICD-10 Finland

Physical abuse

8.4

54.1

124

162

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.2

54.0

154

277

P01

ICPC

Feeling anxious/nervous/tense

3.4

53.9

317

1161

N03AX16

ATC

pregabalin; oral

3.7

53.8

277

915

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

15.7

53.5

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

10.3

53.5

109

116

AA1AD

NOMESCO Finland

CT of head and brain

3.8

53.4

255

790

N05AX13

ATC

paliperidone; systemic

18.0

53.3

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.6

53.2

759

4827

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

21.1

53.0

ZXY60

NOMESCO Finland

2-person team, nurses

23.8

53.0

ZYC01

NOMESCO Finland

Remote contact by phone

6.5

51.8

143

246

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

5.1

51.0

174

387

EBA00

NOMESCO Finland

Extraction of tooth

2.6

50.8

551

2975

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

50.4

Z71.8

ICD-10 Finland

Other specified counselling

2.9

49.8

392

1739

SAA01

NOMESCO Finland

Simple examination of mouth

2.9

49.6

968

7228

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

+∞

49.3

P16

ICPC

Acute alcohol abuse

12.9

49.3

K02.1

ICD-10 Finland

Caries of dentine

2.7

49.2

872

6123

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

9.4

49.1

105

122

IGY99

NOMESCO Finland

Other psychiatric treatment contact

9.1

48.9

106

126

N06AA12

ATC

doxepin; systemic

10.1

48.4

106

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

+∞

48.3

N05AB01

ATC

dixyrazine; systemic

54.3

48.1

X78

ICD-10 Finland

Intentional self-harm by sharp object

25.3

47.6

Z3226

NOMESCO Finland

Physiotherapist

3.5

47.5

255

861

P74

ICPC

Anxiety disorder/anxiety state

5.3

47.5

155

327

WX110

NOMESCO Finland

Local anesthesy

2.8

47.3

939

6945

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

+∞

47.2

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

13.2

47.1

F99

ICD-10 Finland

Mental disorder, not otherwise specified

9.1

47.1

102

121

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.4

46.6

678

4216

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

48.9

46.4

WX290

NOMESCO Finland

Other blockade of nerve

2.5

46.4

767

5091

IEV99

NOMESCO Finland

Other psychiatric network intervention

22.8

46.2

F20.0

ICD-10 Finland

Paranoid schizophrenia

21.8

46.2

F10.09

ICD-10 Finland

Alcohol intoxication UNS

9.6

46.1

109

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

+∞

46.1

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

9.9

46.1

103

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.0

45.9

329

1364

F39

ICD-10 Finland

Unspecified mood [affective] disorder

7.9

45.6

108

148

F05.9

ICD-10 Finland

Delirium, unspecified

37.4

44.8

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

454.2

44.5

N06AB05

ATC

paroxetine; oral

5.4

44.2

142

293

RS220

NOMESCO Finland

20.5

44.0

-1

NOMESCO Finland

2.4

42.7

568

3317

P98

ICPC

Psychosis NOS/other

15.0

42.2

B17.1

ICD-10 Finland

Acute hepatitis C

152.2

42.0

S01.0

ICD-10 Finland

Open wound of scalp

5.0

41.6

142

313

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.9

41.3

143

320

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

22.5

41.3

IEY01

NOMESCO Finland

Psychoeducation, individual

13.9

40.9

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

40.9

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

40.9

XF400

NOMESCO Finland

ECG with 12 standard connections

3.8

40.5

188

558

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

38.0

40.3

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

11.9

40.2

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

20.3

40.0

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

40.1

40.0

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

+∞

39.8

F12.09

ICD-10 Finland

Intoxication caused by cannabis UNS

+∞

39.8

F12.00

ICD-10 Finland

Intoxication caused by cannabis uncomplicated

+∞

39.8

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

+∞

39.8

N05AD03

ATC

melperone; systemic

42.6

39.7

F22.0

ICD-10 Finland

Delusional disorder

12.7

39.3

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

19.1

39.2

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

13.0

39.1

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

34.7

38.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.4

38.3

214

732

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

3.8

38.3

177

522

K04.0

ICD-10 Finland

Pulpitis

3.1

38.2

242

908

SPAT1307

SPAT

Psychosocial counselling and guidance

3.5

38.2

202

665

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.2

38.2

156

412

N03AX12

ATC

gabapentin; oral

3.7

38.2

185

568

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

13.9

38.1

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

19.9

37.8

S06.0

ICD-10 Finland

Concussion

3.3

37.7

209

713

F20

ICD-10 Finland

Schizophrenia

17.0

37.6

N06AX03

ATC

mianserin; oral

8.2

37.0

111

F21

ICD-10 Finland

Schizotypal disorder

21.7

36.8

F12.2

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, dependence syndrome

+∞

36.6

F12.3

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, withdrawal state

+∞

36.6

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

+∞

36.6

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

36.5

311

1403

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

22.1

36.4

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

8.7

36.2

S18

ICPC

Laceration/cut

2.3

35.9

429

2319

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.1

35.7

119

255

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

20.5

35.5

EBA30

NOMESCO Finland

Excision of root of tooth

6.0

35.5

102

183

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.0

35.4

119

257

L17

ICPC

Foot/toe symptom/complaint

2.7

35.3

292

1291

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

24.3

34.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

34.6

566

3523

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

34.6

365

1844

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

10.3

34.4

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

18.5

34.3

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.6

33.6

114

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

8.5

33.5

F31

ICD-10 Finland

Bipolar affective disorder

12.3

33.4

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.3

33.3

2432

OAB43

SPAT

0.3

33.0

2087

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

28.5

32.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

32.6

223

874

P27

ICPC

Fear of mental disorder

9.2

32.5

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

+∞

32.4

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

14.4

32.3

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

18.9

32.0

ZXD05

NOMESCO Finland

Urgent procedure

2.3

31.9

380

2025

SPAT1254

SPAT

Administration of medicine

3.0

31.7

207

783

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

+∞

31.4

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

+∞

31.4

F40.1

ICD-10 Finland

Social phobias

5.1

31.3

103

217

Z3229

NOMESCO Finland

Other healthcare associate professional

4.4

31.2

121

302

188

Kela drug reimbursment

Psychosis requiring demanding treatment

14.7

30.9

SPAT1234

SPAT

Support of social functional capacity

6.6

30.8

133

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

18.8

30.7

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

39.2

30.4

SPAT1240

SPAT

Therapeutic discussion

2.7

30.3

244

1052

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

18.1

30.3

SGA01

NOMESCO Finland

Tooth opening as first aid

2.5

30.1

293

1403

D10

ICPC

Vomiting

3.3

30.1

166

558

IGP01

NOMESCO Finland

Psychiatric family contact

17.4

29.9

P76

ICPC

Depressive disorder

3.4

29.9

156

504

ZYD01

NOMESCO Finland

Emergency clinic

31.0

29.6

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.9

29.5

130

365

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

29.5

370

2003

SPAT1247

SPAT

Outpatient detoxication and monitoring

27.5

29.4

F51.0

ICD-10 Finland

Nonorganic insomnia

2.8

29.4

221

912

F19.51

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid

+∞

29.3

S76

ICPC

Skin infection other

5.6

29.3

167

N05CD02

ATC

nitrazepam; oral

58.3

29.2

F41.09

ICD-10 Finland

UNS Panic Syndrome

5.0

29.2

211

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

25.8

28.9

N05CD08

ATC

midazolam; nasal, systemic

20.2

28.9

A06AD11

ATC

lactulose; oral

4.0

28.7

123

337

WX892

NOMESCO Finland

Monitored bed care

4.4

28.1

107

262

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

2.1

28.1

452

2718

T51.0

ICD-10 Finland

Toxic effect: Ethanol

13.4

28.1

KMAK

NOMESCO Finland

2.0

28.0

717

5175

L03

ICPC

Low back symptom/complaint

2.3

27.9

297

1480

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

148.5

27.7

N06BA04

ATC

methylphenidate; oral

4.7

27.7

223

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

7.5

27.6

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

48.4

27.5

RS140

NOMESCO Finland

23.7

27.5

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

9.5

27.4

R44.0

ICD-10 Finland

Auditory hallucinations

30.9

27.3

S29

ICPC

Skin symptom/complaint other

2.8

27.3

201

818

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

+∞

27.2

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

+∞

27.2

P06

ICPC

Sleep disturbance

2.9

27.1

179

679

V03AA01

ATC

22.4

27.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

8.2

26.9

TKC20

NOMESCO Finland

Catheterisation of bladder

5.8

26.8

142

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

99.1

26.8

N02AX02

ATC

tramadol; systemic, rectal

2.1

26.7

373

2102

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

11.1

26.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

18.4

26.7

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

7.1

26.6

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

35.0

26.6

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

46.9

26.6

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

14.1

26.4

S10

ICPC

Boil/carbuncle

4.2

26.4

105

268

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

780

2085

8.18

313.00

3.5

1.7

1.4

26.47

699

1917

(3027944) Amphetamines [Presence] in Urine

727

1330

11.54

307.65

8.7

1.4

—

(3028300) Cannabinoids [Presence] in Urine

751

1357

12.20

307.65

9.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

643

464

27.21

307.65

9.1

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

221

39.19

307.65

2.2

1.2

—

(4198724)

282

43.46

307.65

4.6

1.4

—

(3016879) Cocaine [Presence] in Urine

742

1252

12.96

307.65

9.1

1.4

—

(3011288) Drugs identified in Urine by Screen method

730

841

19.22

307.65

11.7

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

722

1019

15.22

307.65

8.7

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

750

1344

12.29

307.65

9.2

1.4

—

(3027008) Opiates [Presence] in Urine

748

1354

12.11

307.65

9.2

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

725

2222

6.32

237.58

9.7

3.0

mmol/l

7.5

9.6

14.64

634

1941

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

855

3165

6.28

221.64

4.7

3.2

u/l

40.3

32.4

2.51

801

3014

(3009466) Valproate [Moles/volume] in Serum or Plasma

208

194

12.64

198.29

6.7

5.0

umol/l

378.9

379.2

0.01

185

169

(3042517) Benzodiazepines panel - Urine

103

93.37

196.77

4.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

179

140

14.73

189.99

4.2

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

115

18.51

140.85

1.9

3.1

nmol/l

132.7

143.0

0.33

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

682

2766

4.19

138.83

5.9

mmol/l

1.2

2.02

615

2544

(3019309) Folate [Moles/volume] in Red Blood Cells

333

788

5.38

137.07

1.7

1.6

nmol/l

980.2

1149.1

2.59

253

625

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

813

3759

4.27

136.46

6.0

5.8

umol/l

9.8

11.3

5.68

756

3571

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1068

6121

5.85

131.39

8.0

6.8

u/l

75.7

73.0

1.93

1020

5803

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

709

3078

3.97

128.05

6.5

6.4

mmol/l

1.2

2.86

580

2614

(3019150) Specific gravity of Urine by Refractometry

521

1840

4.12

126.93

6.6

2.6

kg/l

1.0

0.03

234

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

124

106

12.86

123.73

14.1

10.9

mmol/l

0.6

0.73

107

(44816559) Phosphatidylethanol [Mass/volume] in Blood

198

326

7.02

118.50

1.8

1.3

—

(40758558) Short blood count panel - Blood

536

2024

3.87

116.82

13.8

7.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

537

2068

3.78

112.96

2.5

3.0

mmol/l

2.4

0.23

485

1886

(3017143) Hepatitis C virus Ab [Presence] in Serum

543

2109

3.76

112.72

2.1

1.7

—

(42870588) Differential panel, method unspecified - Blood

647

2824

3.65

112.01

7.1

6.6

—

(3018418) pH of Serum or Plasma

500

1845

3.83

111.98

2.6

4.2

7.4

0.72

363

(46235355) HIV 1 and 2 tests - Meaningful Use set

773

3838

3.62

107.96

2.9

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

637

2819

3.54

106.61

4.2

5.3

g/l

36.4

38.1

8.19

587

2639

(3013826) Glucose [Moles/volume] in Serum or Plasma

829

4354

3.63

104.73

6.1

4.5

mmol/l

6.4

0.15

775

3962

(3021589) Normoblasts [#/volume] in Blood

779

3940

3.55

104.48

12.4

8.2

e9/l

0.0

0.88

635

3199

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

558

2305

3.55

103.58

2.0

1.6

pmol/l

97.7

98.0

0.06

311

1267

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

44.95

100.84

9.8

9.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

627

2844

3.39

99.02

2.1

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

490

1910

3.56

98.86

3.0

2.1

u/l

421.5

317.6

0.71

457

1819

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

259

645

4.79

98.08

4.4

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

154.97

95.58

1.2

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

225

520

5.05

93.01

2.8

3.6

kpa

6.0

5.9

0.20

208

508

(3013650) Neutrophils [#/volume] in Blood by Automated count

889

5116

3.50

91.91

23.8

9.1

e9/l

4.4

4.0

4.94

785

4507

(3002032) Base excess in Venous blood by calculation

221

514

5.00

90.56

2.8

3.7

mmol/l

1.8

1.7

0.12

168

421

(3013115) Eosinophils [#/volume] in Blood

834

4653

3.34

90.10

13.3

6.7

e9/l

0.2

1.31

727

4191

(3024354) Oxygen [Partial pressure] in Venous blood

196

413

5.43

90.02

2.4

2.9

kpa

5.4

5.0

1.40

179

404

(3001604) Monocytes [#/volume] in Blood

814

4482

3.30

89.84

9.6

6.4

e9/l

0.6

7.87

694

3982

(3006315) Basophils [#/volume] in Blood

813

4492

3.28

88.82

9.7

6.4

e9/l

0.0

2.79

693

3982

(3021960) Folate [Moles/volume] in Serum or Plasma

353

1194

3.72

87.20

1.5

1.4

nmol/l

16.4

20.0

5.77

327

1076

(3033658) Prothrombin time (PT) actual/Normal

474

1936

3.32

86.79

5.0

4.1

90.9

94.2

2.19

454

1892

(3022096) Basophils/100 leukocytes in Blood

760

4096

3.15

85.57

9.3

6.4

0.6

0.7

2.69

714

3901

(3014111) Lactate [Moles/volume] in Serum or Plasma

221

539

4.76

85.24

8.1

7.6

mmol/l

1.6

1.5

0.49

209

519

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

275

798

4.13

84.49

2.9

2.6

u/l

197.5

40.9

0.46

243

699

(3016650) Hepatitis A virus Ab [Presence] in Serum

136

223

6.71

80.88

1.3

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

823

4739

3.12

80.52

9.7

6.2

e9/l

2.2

2.0

12.47

714

4284

(3019069) Monocytes/100 leukocytes in Blood

770

4292

3.04

79.54

9.5

6.5

8.3

8.4

0.15

727

4104

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

159

309

5.74

79.50

2.9

3.7

mmol/l

24.3

24.0

0.40

141

285

(3006504) Eosinophils/100 leukocytes in Blood

763

4252

3.01

78.48

9.3

6.3

2.6

2.8

1.92

716

4034

(3020191) Ethanol [Moles/volume] in Serum or Plasma

104

9.69

78.11

1.6

1.4

promille

1.1

1.5

1.19

(3023368) Bacteria identified in Blood by Culture

410

1641

3.22

76.15

6.8

4.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

368

1394

3.31

74.77

1.9

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

127

215

6.46

73.06

1.3

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

783

4541

2.91

72.69

9.3

6.2

30.1

30.2

0.00

737

4347

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1016

6872

3.45

70.05

4.5

3.4

pmol/l

14.7

14.6

0.38

941

6352

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

496

2317

2.88

68.69

3.1

2.6

u/l

51.3

55.3

1.72

440

2167

(3019550) Sodium [Moles/volume] in Serum or Plasma

1192

9037

6.75

68.14

19.7

9.1

mmol/l

139.4

139.7

4.06

1170

8749

(3023103) Potassium [Moles/volume] in Serum or Plasma

1195

9083

6.95

67.98

19.5

9.2

mmol/l

3.9

0.87

1169

8769

(3000991) Gas panel - Venous blood

191

493

4.39

67.87

9.1

9.3

—

(3018010) Neutrophils/100 leukocytes in Blood

764

4476

2.79

67.75

9.2

6.0

55.3

55.7

0.42

718

4286

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

108

8.68

67.36

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1083

7794

3.75

63.64

6.6

2.7

u/l

45.9

39.8

2.20

1043

7522

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1123

8300

4.21

62.68

6.0

3.8

mu/l

1.6

2.0

1.41

1055

7856

(3044889) 12 lead EKG panel

849

5385

2.76

62.06

4.0

2.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

140

305

5.04

61.16

1.9

1.5

—

(3042936) Bacteria identified in Isolate by Culture

277

1007

3.24

58.87

2.3

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

273

994

3.23

57.79

2.0

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

259

914

3.31

57.73

2.5

3.0

umol/l

6.6

7.3

0.32

199

787

(3023183) Ammonium ion [Moles/volume] in Plasma

132

7.00

55.35

2.4

3.9

umol/l

37.7

35.9

0.22

116

(3014576) Chloride [Moles/volume] in Serum or Plasma

216

708

3.47

53.97

8.3

8.0

mmol/l

104.6

104.4

0.11

208

692

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

14.03

53.86

5.7

5.0

umol/l

151.5

214.5

0.31

(3030467) Casts [#/volume] in Urine by Automated count

409

1927

2.66

53.31

2.8

2.7

e6/l

0.4

0.3

0.51

305

1398

(3018095) Leukocytes [#/volume] in Urine

502

2620

2.52

52.74

3.4

3.2

e6/l

106.3

63.8

0.31

343

1742

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

206

666

3.50

52.51

2.0

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

436

2139

2.59

52.10

2.9

2.7

e6/l

39.8

107.4

0.60

331

1608

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

145

369

4.31

52.03

1.5

1.4

—

(3003396) Base excess in Arterial blood by calculation

189

582

3.64

51.87

9.9

9.8

mmol/l

1.3

0.7

0.96

146

443

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

208

683

3.45

51.71

2.0

1.6

—

(3017509) Phencyclidine [Presence] in Urine

18.07

51.69

5.8

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

198

631

3.54

51.56

1.6

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

186

583

3.57

49.60

10.1

9.8

kpa

5.4

5.0

4.30

177

548

(3027801) Oxygen [Partial pressure] in Arterial blood

186

583

3.57

49.60

10.1

9.7

kpa

12.2

13.9

2.83

177

552

(36304419) Bacteria [Presence] in Urine

405

1964

2.56

49.11

2.7

2.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

481

2527

2.46

49.07

2.8

—

(3032080) INR in Blood by Coagulation assay

457

2355

2.47

48.54

5.3

5.6

inr

1.0

1.1

2.51

182

839

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

102

212

5.15

46.83

2.4

2.9

ug/l

659.9

329.3

0.63

200

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

116

282

4.43

44.01

12.4

11.9

mmol/l

24.4

24.0

0.53

110

269

(3031040) Bacteria [#/volume] in Urine by Automated count

761

5030

2.29

43.89

4.1

3.2

e6/l

106.6

306.0

0.42

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

182

608

3.33

43.67

2.3

2.6

g/l

0.2

6.03

155

564

(3012095) Magnesium [Moles/volume] in Serum or Plasma

257

1049

2.82

43.40

3.3

4.3

mmol/l

0.8

0.63

234

1001

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

409

3.79

42.73

1.4

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1115

8838

3.25

42.25

15.1

7.9

ml/min/173m2

105.9

99.7

20.92

894

7049

(3007853) Bacteria identified in Skin by Aerobe culture

243

976

2.85

42.21

2.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

234

923

2.88

42.03

2.4

2.8

mmol/l

2.4

2.10

195

804

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1079

8451

2.91

40.81

5.0

2.9

mmol/l

5.8

5.7

2.10

1010

7951

(3016502) Oxygen saturation in Arterial blood

159

516

3.38

39.83

10.7

95.5

96.8

1.86

154

490

(3026782) Osmolality of Urine

295

1343

2.56

39.77

2.5

2.4

mosm/kgh2o

499.1

581.8

6.58

257

1165

(3023511) Choriogonadotropin [Units/volume] in Urine

126

353

3.85

39.38

1.7

1.3

—

(21494755) Public health laboratory ask at order entry panel

2138

0.14

39.30

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

152

489

3.40

38.57

10.7

g/l

127.7

129.5

0.47

147

464

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

6.67

38.21

5.0

3.1

—

(3002385) Erythrocyte distribution width [Ratio]

1086

8631

2.85

38.04

31.3

11.3

13.5

13.2

8.80

1076

8457

(3024928) Oxygen saturation in Venous blood

129

5.77

37.70

2.1

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

527

3179

2.13

35.97

2.2

2.3

nmol/l

59.7

69.4

12.80

488

2988

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

266

1213

2.51

35.35

3.3

2.9

ng/l

136.4

729.9

2.64

150

672

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1173

9857

3.69

34.61

17.9

9.3

mg/l

21.2

21.1

0.03

968

7262

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

245

1085

2.56

34.57

2.3

2.4

e6/l

3.5

2.2

0.95

106

532

(3000850) Epithelial cells [#/volume] in Urine

292

1412

2.39

33.98

2.6

2.4

e6/l

6.5

6.2

0.12

269

1248

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

246

1123

2.48

32.38

2.2

2.3

e6/l

1.2

0.8

0.59

108

571

(3013707) Erythrocyte sedimentation rate by Westergren method

843

6198

2.08

32.20

3.2

3.4

mm/h

8.7

7.0

3.48

760

5827

(3003458) Phosphate [Moles/volume] in Serum or Plasma

201

836

2.67

32.08

4.9

7.4

mmol/l

1.1

1.0

1.04

188

791

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1211

10542

4.68

30.58

13.9

7.6

u/l

39.2

31.9

3.15

1189

10271

(1616796) Gas panel - Central venous blood

156

4.76

30.42

3.2

3.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

480

2937

2.02

30.25

2.6

2.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1196

10380

3.91

29.15

18.2

9.5

umol/l

71.8

76.3

9.45

1196

10375

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

244

1167

2.35

28.67

1.7

1.5

pmol/l

444.5

25859205.2

1.32

198

1048

(3026008) Bacteria identified in Urine by Culture

287

1474

2.23

28.46

2.8

2.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

150

571

2.85

28.24

4.7

9.5

mmol/l

6.5

7.2

0.78

144

549

(3052851) Hemolysis interference index of Serum or Plasma

203

4.08

27.72

2.5

2.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

500

3180

1.95

27.58

2.9

2.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

140

524

2.88

27.17

9.7

11.0

inr

1.0

1.1

1.65

(3037467) Urinalysis macro (dipstick) panel - Urine

772

5740

1.89

25.62

3.6

3.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

17.78

25.57

4.5

1.9

—

(1761868) Lipid panel - Serum or Plasma

249

4340

0.47

25.17

2.7

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

341

1954

2.02

24.97

1.6

mmol/l

1.9

1.5

2.59

308

1750

(3027945) Reticulocytes/100 erythrocytes in Blood

133

516

2.76

24.06

2.7

3.6

1.7

0.20

115

469

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1645

0.22

23.27

1.1

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

289

1613

2.03

22.49

2.0

mg/l

2.6

0.01

230

1410

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

300

3.15

21.33

11.1

13.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

155

694

2.41

20.79

2.0

1.6

mu/l

507.6

278.0

3.80

124

628

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

137

581

2.52

20.66

1.3

miu/ml

226.0

239.5

0.10

289

(3011397) Hemoglobin [Presence] in Urine by Test strip

293

1704

1.94

19.99

2.6

2.8

—

(3012501) Base excess in Blood by calculation

182

3.65

19.47

3.8

3.0

mmol/l

2.2

0.03

126

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

473

2.62

19.45

2.4

1.8

—

(3010421) pH of Blood

212

3.44

19.36

3.7

2.9

7.4

2.49

181

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.80

19.19

1.8

1.9

umol/l

12.2

15.3

0.90

(3021901) Oxygen saturation in Capillary blood

4.85

18.79

2.3

2.4

—

(3013512) EKG study

271

1576

1.92

18.32

3.4

2.4

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

17.75

2.6

0.0

ug/l

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2185

0.40

17.70

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1134

0.19

17.57

1.1

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

112

473

2.50

16.98

2.3

3.5

mmol/l

1.2

0.56

413

(3004789) Transferrin [Mass/volume] in Serum or Plasma

176

911

2.08

16.45

1.6

2.4

g/l

2.5

2.4

1.26

152

851

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

3.70

16.29

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

3.70

16.29

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

182

963

2.04

16.01

1.9

2.9

30.1

29.7

0.42

177

937

(3023520) Reticulocytes [#/volume] in Blood

323

2.75

15.94

1.9

3.6

e9/l

74.0

75.0

0.07

226

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

364

2404

1.72

15.86

3.5

2.5

ng/l

19.0

132.5

0.59

204

1098

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

109

3.95

14.57

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

345

2.57

14.00

3.1

2.8

kpa

5.6

5.1

3.91

324

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

142

720

2.10

13.95

3.4

2.7

u/l

16792.8

3929.5

1.57

282

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

330

2.59

13.74

2.9

2.8

mmol/l

2.3

1.0

2.16

237

(3009343) pH of Capillary blood

343

2.55

13.66

3.0

2.8

7.4

0.20

(40761511) CBC panel - Blood by Automated count

1159

10575

2.18

13.17

17.6

8.0

—

(3044640) Blood type and Crossmatch panel - Blood

336

2287

1.64

12.60

2.6

2.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

173

976

1.90

12.51

1.6

2.4

umol/l

13.9

15.5

1.52

159

912

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

914

7823

1.61

12.50

4.6

3.7

mmol/mol

36.8

37.5

1.21

835

7511

(3008152) Bicarbonate [Moles/volume] in Arterial blood

310

2.54

12.40

7.9

9.5

mmol/l

25.4

24.1

1.85

280

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

113

549

2.16

12.37

2.1

3.6

pmol/l

4.5

4.8

1.60

502

(3003181) Sodium [Moles/volume] in Urine

4.82

12.16

1.3

1.4

mmol/l

64.6

71.6

0.19

(3019060) Gas panel - Arterial blood

315

2.50

12.00

5.3

7.0

—

(3020891) Body temperature

204

2.88

11.98

4.8

4.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

334

2.46

11.96

1.1

1.4

titre

56.0

80.5

—

(3011648) Oxygen content in Venous blood

4.88

11.46

1.6

2.5

13.3

12.3

0.44

(40761536) Microorganisms panel - Urine sediment

139

752

1.95

11.37

3.9

3.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

150

834

1.91

11.31

1.8

2.5

22.3

26.3

2.01

127

738

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

194

2.81

10.71

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

130

3.23

10.62

2.6

2.1

17.2

17.9

0.47

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

18.95

10.27

1.5

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

188

2.78

10.18

4.2

4.1

54.9

55.4

0.10

188

(3030905) Polymorphonuclear cells [#/volume] in Blood

184

2.79

10.02

4.2

3.9

e9/l

4.2

3.9

0.58

184

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

132

734

1.89

9.93

6.2

4.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

273

1869

1.59

9.68

2.3

2.0

mg/l

1.3

0.9

0.95

168

1257

(3019832) Treponema pallidum Ab [Presence] in Serum

318

2271

1.54

9.32

2.0

1.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

774

0.28

9.28

1.5

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

142

2.95

9.19

5.0

mmol/l

3.7

3.8

0.88

130

(3029937) Albumin [Presence] in Urine by Test strip

299

2135

1.52

8.69

3.5

3.0

estimate

0.0

1.08

112

794

(3017181) Myelocytes/100 leukocytes in Blood

116

654

1.85

8.36

5.5

4.6

0.4

0.7

1.10

158

(3021440) Promyelocytes/100 leukocytes in Blood

113

633

1.86

8.31

5.6

4.6

0.1

0.40

151

(3021601) Nitrite [Presence] in Urine by Test strip

519

4161

1.42

8.21

3.9

3.8

estimate

0.0

0.50

119

826

(3007461) Platelets [#/volume] in Blood

1222

11664

2.50

7.99

35.9

13.0

e9/l

255.0

252.9

0.51

1205

11406

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

208

2.46

7.91

1.4

2.2

g/l

1.7

1.4

1.16

189

(3035350) Ketones [Presence] in Urine by Test strip

517

4163

1.41

7.89

3.0

2.7

estimate

0.0

0.40

111

790

(3006184) Hemoglobin [Mass/volume] in Capillary blood

127

2.89

7.84

2.0

2.5

g/l

136.8

138.4

0.12

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.24

7.72

1.4

e6/l

8469.0

11530.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

247

1736

1.53

7.64

2.6

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

18.48

7.60

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

519

4201

1.40

7.60

3.1

2.7

estimate

0.0

0.00

111

779

(3023199) Leukocytes [#/volume] in Pleural fluid

5.65

7.55

1.4

1.3

e6/l

16975.2

2811.6

—

(3024731) MCV [Entitic volume]

1222

11691

2.43

7.45

35.7

12.9

89.9

89.1

10.22

1213

11567

(3035941) MCH [Entitic mass]

1222

11692

2.42

7.44

35.7

12.9

30.2

30.0

3.23

1213

11567

(3026361) Erythrocytes [#/volume] in Blood

1222

11695

2.42

7.38

35.8

13.0

e12/l

4.7

4.8

9.89

1199

11429

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

228

1588

1.53

7.33

2.6

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1038

9505

1.52

7.32

4.2

3.2

mmol/l

2.8

2.9

7.89

959

9080

(3000963) Hemoglobin [Mass/volume] in Blood

1222

11703

2.39

7.22

36.1

13.0

g/l

140.5

143.3

9.17

1213

11567

(3010813) Leukocytes [#/volume] in Blood

1222

11707

2.38

7.14

36.0

13.0

e9/l

7.5

6.5

44.43

1200

11440

(3045788) Cell count panel - Pleural fluid

6.05

6.91

1.5

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

105

610

1.79

6.88

4.4

4.3

0.3

0.5

0.62

123

(3036481) Cortisol [Moles/volume] in Serum or Plasma

135

847

1.66

6.72

2.0

1.9

nmol/l

375.2

377.6

0.05

115

792

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

4.04

6.63

2.3

3.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

375

1.98

6.61

2.0

ug/l

3.0

10.5

6.79

341

(3012441) Differential panel - Pleural fluid

5.24

6.49

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

256

2.16

6.37

1.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

18.11

6.27

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

3.55

6.17

1.8

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

151

2.49

6.15

2.3

2.6

—

(3016018) Differential panel - Cerebral spinal fluid

110

2.77

6.14

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.05

6.09

2.1

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

184

1273

1.52

6.06

2.5

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

308

2380

1.39

5.62

7.5

4.4

—

(3000494) Fungus identified in Specimen by Culture

147

984

1.56

5.62

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

12.94

5.58

2.2

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

210

2.19

5.56

1.7

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

101

619

1.69

5.51

1.5

u/l

6.0

6.7

0.37

521

(3023410) Appearance of Cerebral spinal fluid

111

2.65

5.50

1.8

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

442

3630

1.33

5.43

4.1

3.7

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

16.09

5.41

1.0

—

(3022313) Gas panel - Capillary blood

241

2.07

5.31

2.9

—

(3008295) Osmolality of Serum or Plasma

2.91

5.21

3.1

1.7

mosm/kgh2o

284.0

286.3

0.19

(3039443) Prostate specific Ag panel - Serum or Plasma

246

0.20

5.18

1.2

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1019

9467

1.40

5.13

3.9

3.1

mmol/l

4.4

4.7

18.81

951

9104

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.78

5.10

2.1

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

1095

10310

1.47

5.06

27.6

9.5

41.2

42.3

5.73

809

8969

(3025159) Blasts/100 leukocytes in Blood

612

1.65

5.00

6.2

4.7

0.0

0.1

1.23

130

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

9.05

4.78

2.1

1.4

nmol/l

25.4

14.1

—

(3019225) pH of Specimen

542

1.67

4.74

4.2

3.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

252

1.98

4.74

1.7

1.5

e6/l

626.9

788.7

0.07

203

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

252

1.98

4.74

1.7

1.4

e6/l

38.6

14.4

0.94

197

(3044290) Cell count panel - Cerebral spinal fluid

239

2.00

4.69

1.8

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

103

2.56

4.65

1.8

2.4

0.5

1.4

1.62

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

213

2.05

4.61

1.8

1.5

—

(3047181) Lactate [Moles/volume] in Blood

186

2.13

4.61

6.1

8.4

mmol/l

1.2

0.09

151

(40761535) Cells panel - Urine sediment

470

1.70

4.57

3.0

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

884

9522

0.76

4.56

3.7

—

(3006653) Thiamine [Moles/volume] in Blood

3.85

4.54

1.1

1.2

nmol/l

156.0

148.3

0.14

(3017446) Testosterone [Moles/volume] in Serum or Plasma

183

1342

1.43

4.46

2.7

2.3

nmol/l

12.5

14.7

3.12

152

1261

(40768797) Stomach Pathology biopsy report

133

920

1.50

4.38

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1009

9426

1.35

4.37

3.8

3.1

mmol/l

1.2

1.3

22.95

933

9046

(3044242) Glucose [Moles/volume] in Arterial blood

4.10

4.16

1.7

3.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

709

0.51

4.14

1.8

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.48

4.06

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

481

4127

1.27

3.95

2.6

2.7

ug/l

97.0

106.8

0.59

433

3916

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.15

3.93

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

132

2.23

3.88

1.3

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

971

9071

1.31

3.84

3.5

2.9

mmol/l

1.5

1.3

7.02

892

8703

(3035880) pH of Pleural fluid

8.79

3.77

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

284

2290

1.31

3.77

1.3

1.4

g/l

2.3

2.2

0.19

145

1560

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.47

3.73

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.47

3.73

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

312

1.76

3.71

3.2

3.1

ng/l

73.1

100.9

0.50

261

(3035947) Staphylolysin Ab [Units/volume] in Serum

3.27

3.63

1.1

1.2

—

5.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

541

1.57

3.62

1.4

1.5

iu/l

12.1

13.6

0.31

451

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

105

2.31

3.53

1.3

1.7

—

(40768806) Pleura Pathology biopsy report

3.87

3.52

1.6

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

595

1.53

3.48

1.2

1.8

g/l

1.6

1.2

1.85

550

(3003740) Influenza virus B Ag [Presence] in Specimen

334

0.35

3.48

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

106

2.29

3.47

1.8

1.5

g/l

39.2

39.7

0.17

(3002523) Influenza virus A Ag [Presence] in Specimen

333

0.35

3.46

1.0

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

110

770

1.47

3.45

1.3

2.4

g/l

11.8

10.5

1.94

102

696

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.00

3.42

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

310

2562

1.28

3.38

1.3

u/ml

3.2

1.7

0.39

705

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

2.17

3.33

1.8

1.5

g/l

11.1

10.4

0.29

111

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

115

2.20

3.30

1.7

1.5

g/l

0.1

0.6

0.87

107

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

136

1007

1.39

3.16

2.8

3.4

ng/l

1177.0

690.8

0.39

101

768

(3017354) Segmented neutrophils/100 leukocytes in Blood

2.64

3.14

1.8

2.5

57.7

58.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

2.08

3.14

1.7

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

529

1.53

3.09

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

101

713

1.45

3.06

1.0

—

(3037522) Nuclear Ab [Titer] in Serum

167

1289

1.34

3.00

1.2

1.4

titre

329.6

438.2

0.58

198

(3012516) Albumin [Mass/volume] in Urine

191

1506

1.32

2.96

3.1

3.7

mg/l

113.3

301.1

1.16

123

1055

(3014133) Dog dander IgE Ab [Units/volume] in Serum

293

0.37

2.95

1.1

u/ml

10.8

5.0

—

125

(3026250) Tacrolimus [Mass/volume] in Blood

0.00

2.78

0.0

34.7

—

7.8

—

(3042631) Mycobacterium sp identified in Specimen

2.52

2.70

2.6

2.8

—

(3000012) Reticulocyte production index

4.23

2.68

1.3

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.77

2.67

1.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.77

2.67

1.6

2.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

277

1.65

2.55

1.9

3.7

g/l

3.5

3.4

0.21

268

(3023430) Cat dander IgE Ab [Units/volume] in Serum

269

0.40

2.47

1.1

u/ml

17.6

5.8

—

119

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.40

2.46

2.0

2.4

—

(4094501)

160

0.31

2.42

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

243

1.67

2.40

1.5

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

194

1580

1.27

2.36

4.3

4.5

mg/mmol

23.7

13.7

0.46

125

1103

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

478

1.47

2.36

1.9

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

344

0.49

2.35

1.1

u/ml

0.9

1.8

0.66

154

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

284

1.61

2.33

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

285

1.60

2.31

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

354

0.50

2.29

1.2

1.1

u/ml

2.0

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

135

1.87

2.23

1.9

6.3

u/ml

0.2

0.3

0.76

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

389

0.53

2.23

1.2

1.1

u/ml

0.6

1.4

1.06

168

(42529406) Shigella sp [Presence] in Stool by Culture

288

1.58

2.22

1.1

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

2.21

13.3

8.5

u/ml

4955.0

24529.0

0.36

(3051651) Icteric interference index of Serum or Plasma

2.42

2.20

4.5

3.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

298

1.56

2.16

1.7

3.3

194.9

172.9

0.73

287

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.30

2.15

1.5

1.2

—

(1002224) Polysomnography panel

641

0.64

2.13

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.38

2.12

1.3

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

206

0.43

2.08

2.6

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

206

0.43

2.08

5.1

6.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.12

2.03

1.3

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

241

1.59

1.97

1.9

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

1.96

1.0

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

2.20

1.94

4.4

3.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

166

1.70

1.88

1.2

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

355

0.56

1.88

1.1

u/ml

1.4

7.6

6.11

210

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.18

1.82

1.2

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.18

1.82

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.01

1.80

1.4

1.3

—

68.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

168

0.41

1.79

1.9

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

169

1.67

1.78

1.2

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.18

1.78

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

185

1.64

1.76

1.3

1.4

ug/g

309.5

313.4

0.03

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.91

1.76

1.3

1.5

—

(3001556) Androgen free Index in Serum or Plasma

2.51

1.74

1.9

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.68

1.72

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

1.79

1.71

1.2

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.30

1.70

2.7

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

130

1590

0.80

1.69

2.1

2.4

22.7

21.8

0.12

379

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

973

0.75

1.68

1.5

—

(3036489) Thrombin time

359

1.44

1.68

1.6

2.9

21.5

21.2

0.24

317

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

724

1.31

1.65

2.1

1.9

nmol/l

40.6

34.9

1.45

717

(3000475) Leukocytes [#/volume] in Synovial fluid

127

1.75

1.64

1.7

1.8

e6/l

12849.6

16432.0

0.16

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

165

1380

1.23

1.62

1.2

iu/ml

34.1

19.6

0.70

386

(3026389) Candida sp identified in Specimen by Organism specific culture

106

1.80

1.59

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

183

1.60

1.58

1.5

3.1

nmol/l

1.0

0.9

0.28

167

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.01

1.58

3.0

4.2

—

(40768443) Skin Pathology biopsy report

272

1.49

1.58

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

690

0.71

1.56

1.2

1.3

u/ml

358.9

352.4

0.01

648

(3050129) First trimester maternal screen panel - Serum or Plasma

632

0.70

1.56

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

562

0.68

1.55

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.87

1.50

1.3

1.7

—

(3022145) Colonoscopy Study observation

911

0.75

1.50

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.44

1.48

1.1

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.04

1.43

1.2

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.32

1.43

1.1

1.7

—

(3003338) MCHC [Mass/volume]

994

9611

1.16

1.39

32.9

10.9

g/l

334.8

336.2

5.09

985

9534

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

119

1.69

1.38

1.2

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

104

1.74

1.37

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.95

1.36

1.2

1.0

—

(3002619) Bacteria identified in Specimen by Culture

2.95

1.36

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

266

1.44

1.33

2.1

1.9

—

(3025130) Human papilloma virus identified in Specimen

136

1.63

1.33

2.1

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

509

0.70

1.32

1.6

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

1.32

0.0

1.5

—

6.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

508

0.70

1.31

1.6

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

1.31

0.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

506

0.70

1.29

1.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

176

0.51

1.29

1.1

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.29

1.27

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

119

0.42

1.24

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

245

1.44

1.24

3.3

g/l

0.3

0.03

133

(44813793)

1.91

1.23

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.64

1.21

1.6

1.7

u/l

9.2

16.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.64

1.21

1.0

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.84

1.19

3.3

2.7

36.0

41.7

—

(3016038) Potassium [Moles/volume] in Urine

2.31

1.18

1.3

mmol/l

28.7

39.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.31

1.18

2.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.31

1.18

1.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.11

1.18

1.1

1.6

—

(4024509)

2.11

1.18

1.6

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

186

0.53

1.17

2.2

2.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

507

0.72

1.16

1.5

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.51

1.15

1.4

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.51

1.15

1.4

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.51

1.15

1.4

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.81

1.15

1.2

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.14

0.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

209

0.57

1.13

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

1.71

1.11

1.2

1.4

—

(4010399)

460

1.30

1.11

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

421

0.71

1.09

1.9

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.83

1.09

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.83

1.09

1.3

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

136

1.55

1.09

1.9

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

997

0.81

1.07

1.8

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

2.13

1.05

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.80

1.05

1.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

553

0.75

1.04

1.5

1.8

mg/l

2.2

3.8

1.17

351

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.28

1.03

2.8

3.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

358

0.69

1.03

1.0

1.1

—

3.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

369

1.31

1.01

1.6

1.8

—

(36660697) Celiac disease serology panel - Serum

110

932

1.20

1.01

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

396

1.30

1.00

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.01

1.00

1.0

1.6

—

(3000492) Spirometry study

102

1203

0.83

0.99

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.97

0.0

4.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

467

0.74

0.96

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

182

1.44

0.96

1.2

2.0

g/l

0.6

0.8

0.28

144

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.77

0.94

1.0

1.1

iu/ml

391.4

203.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

101

1185

0.84

0.93

1.7

1.9

ug/l

0.4

0.6

3.15

489

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

367

1.29

0.91

1.7

5.0

ng/l

65.9

86.3

1.09

343

(4062490)

102

1.58

0.90

1.1

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

102

1.58

0.90

1.1

1.3

g/l

2.8

2.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

102

1.58

0.90

1.1

1.3

g/l

6.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

102

1.58

0.90

1.1

1.3

g/l

0.5

0.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.91

0.88

1.3

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.91

0.88

1.3

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.91

0.88

1.3

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.79

0.88

1.3

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

1.56

0.87

1.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.00

0.87

1.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.00

0.87

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.00

0.87

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.00

0.87

1.3

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

320

0.71

0.84

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

162

1814

0.88

0.83

1.7

2.3

umol/l

2880.7

3104.9

0.03

124

1670

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

202

0.64

0.83

1.1

1.4

pmol/l

31.6

68.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

121

1.49

0.83

1.1

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

141

0.56

0.83

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

276

2992

0.90

0.82

1.7

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

408

0.75

0.81

1.6

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

3.6

—

73.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.79

0.0

2.2

—

55.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.82

0.79

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.79

0.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.3

—

(4268621)

131

1.46

0.78

2.6

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

417

0.76

0.78

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

405

0.76

0.77

1.6

1.4

—

(3017704) Immunofixation for Urine

0.00

0.76

0.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

347

0.74

0.75

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.54

0.75

1.6

1.5

—

(4035726)

491

0.79

0.74

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

172

0.64

0.74

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.00

0.72

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

1.67

0.72

1.1

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

182

0.66

0.71

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

242

2620

0.91

0.71

3.2

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.93

0.70

4.0

2.3

—

(3017732) Neutrophils [#/volume] in Blood

630

1.19

0.70

4.2

1.8

e9/l

4.2

4.0

0.24

554

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

157

0.63

0.69

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

1.64

0.68

1.8

2.5

—

(3021788) Differential panel - Synovial fluid

1.48

0.64

1.4

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

102

0.59

0.62

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

368

0.78

0.61

1.6

1.5

—

(3003694) ABO and Rh group [Type] in Blood

321

3021

1.08

0.60

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.60

0.0

1.5

—

0.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.54

0.59

1.4

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

343

0.78

0.58

2.2

5.2

ug/l

3.0

10.1

0.87

263

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

237

1.27

0.58

2.0

1.9

iu/l

2.1

5.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

230

0.74

0.57

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.43

0.56

1.2

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.62

0.55

1.0

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

168

1.32

0.55

2.1

2.8

mg/l

25.0

26.5

0.07

107

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

182

0.71

0.54

1.0

3.6

—

2804.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.42

0.54

1.1

1.9

—

(3008898) HLA-B27 [Presence]

534

0.84

0.53

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

305

0.78

0.53

1.2

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

169

1.31

0.53

1.2

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.62

0.52

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.61

0.52

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.61

0.52

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

132

0.68

0.52

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.50

0.51

1.7

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

288

1.22

0.50

1.4

1.8

—

325.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

269

0.78

0.50

1.5

2.5

mg/l

12.3

9.7

0.79

258

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

302

0.79

0.50

1.2

1.5

—

18.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

136

1.33

0.49

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

223

0.76

0.48

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

739

1.13

0.48

3.3

2.8

28.3

28.8

0.17

558

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.52

0.48

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.47

0.47

2.6

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

751

1.13

0.46

1.2

iu/ml

177.0

132.7

0.25

283

(3004716) Salmonella sp identified in Stool by Organism specific culture

723

1.13

0.46

1.2

1.3

—

(3002256) Pathology report gross observation

866

1.12

0.46

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

253

0.79

0.45

1.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.45

0.44

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

129

0.70

0.43

3.3

3.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

294

1.20

0.43

1.9

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

131

1.30

0.42

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

140

1.29

0.42

1.1

—

(3000330) Specific gravity of Urine by Test strip

249

1.21

0.42

2.3

2.2

—

(3022621) pH of Urine by Test strip

426

1.16

0.41

2.4

2.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.52

0.41

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.41

0.0

1.7

—

4.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.3

—

3.0

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.41

0.0

1.7

—

2.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

2.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.40

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.40

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.40

0.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

137

1269

1.09

0.40

1.2

u/ml

11.8

6.7

0.31

544

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.34

0.40

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

0.67

0.39

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.41

0.39

1.1

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

1.27

0.38

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.35

0.38

2.0

2.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.62

0.35

1.0

1.1

miu/ml

1785.0

1540.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

0.62

0.35

1.0

3.1

e9/l

0.3

0.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

172

1.22

0.34

1.3

1.4

u/l

10.0

12.0

0.23

147

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.35

0.31

1.0

3.4

ug/l

18.7

476.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.72

0.31

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.71

0.31

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

100

0.70

0.30

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

102

1.28

0.30

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

347

3359

1.05

0.28

3.4

2.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

237

0.84

0.28

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

1.21

0.26

1.0

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.70

0.26

1.4

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

188

1.17

0.25

1.3

u/ml

5.5

6.0

0.05

(3045414) Leukocytes [Presence] in Urine

303

1.13

0.23

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

147

0.81

0.23

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

106

1.23

0.23

1.4

1.5

mmol/l

16.0

12.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

348

0.89

0.23

1.1

1.3

u/ml

209.2

218.7

0.14

225

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.74

0.22

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

372

1.11

0.22

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

229

1.14

0.21

1.3

1.5

nmol/l

0.3

0.4

0.13

196

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

248

1.13

0.21

1.8

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

1.19

0.21

1.2

1.3

—

17.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.21

0.0

3.5

—

7.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

6.2

—

0.4

—

(3048879) Bone marrow aspiration report

0.00

0.21

0.0

2.9

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

246.7

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

91.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

0.2

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

131

1249

1.05

0.21

1.5

—

(3018133) Calcium [Moles/volume] in Urine

0.00

0.21

0.0

1.8

—

3.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3036603) Volume of Urine

1.23

0.20

1.3

1.7

—

2084.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

114

0.79

0.20

3.3

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

151

1573

0.95

0.19

2.1

2.9

ug/g

136.0

128.0

0.09

102

1278

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

165

0.85

0.19

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

362

0.91

0.17

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

621

1.07

0.17

1.2

1.3

—

33.6

—

(44790049)

1.22

0.17

1.2

1.9

—

(44790047)

1.22

0.17

1.2

1.9

—

(44806118)

1.22

0.17

1.2

1.9

—

(44790048)

1.22

0.17

1.2

1.9

—

(40768795) Lymph node Pathology biopsy report

0.76

0.17

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.73

0.17

1.2

—

(40768441) Liver Pathology biopsy report

1.13

0.16

1.0

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

111

1.17

0.15

1.1

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

0.77

0.15

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

121

1.16

0.15

1.1

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

0.84

0.13

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.18

0.12

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

147

0.88

0.11

1.1

1.4

mmol/l

5.5

6.9

—

103

(4027681)

105

1.14

0.11

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.14

0.10

1.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

193

1.09

0.10

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.09

0.09

1.4

1.5

nmol/l

1.0

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.05

0.08

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.77

0.08

1.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

236

0.93

0.08

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

133

0.90

0.07

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.12

0.07

1.0

1.3

—

32.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

0.89

0.07

1.5

3.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

122

0.90

0.07

1.0

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

320

3172

1.01

0.05

2.0

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

211

2089

1.01

0.04

2.4

2.5

ug/l

1.2

0.18

164

1935

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

261

0.96

0.04

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

663

0.98

0.03

1.2

—

(4034850)

260

1.04

0.03

11.1

7.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

102

1.08

0.03

1.4

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

138

0.94

0.02

1.5

1.7

mmol/l

7.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

540

1.02

0.02

2.9

2.2

ml/min/173m2

94.8

82.5

0.83

207

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.06

0.01

1.0

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

222

0.99

0.00

2.1

2.3

umol/l

3.0

5.9

2.47

169

(3025941) Bacteria identified in Stool by Culture

621

1.00

0.00

1.4

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

103

0.97

0.00

1.0

1.3

—

(3049717) Cytology report of Urine Cyto stain

135

0.96

0.00

1.6

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

125

0.96

0.00

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.87

0.00

2.7

2.3

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.2

—

38.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.91

0.00

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.89

0.00

1.2

2.9

—

(3025315) Body weight

0.00

0.0

1.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.93

0.00

1.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

9.1

—

(3034426) Prothrombin time (PT)

1.02

0.00

1.2

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

3.6

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

18.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.92

0.00

1.0

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

165.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

0.96

0.00

1.2

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

190

1.00

0.00

1.3

u/ml

8.8

4.6

0.31

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.90

0.00

1.3

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

491.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.6

—

0.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

157.8

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

25.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.0

4.3

—

0.5

—

(4306422)

190

1.00

0.00

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

2.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.6

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.8

—

3.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_CANNABIS and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_CANNABIS	10.921 [7.35, 16.22]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.928

During the follow-up period (1.1.1998 — 31.12.2019), 195 out of 3066 females with F5_CANNABIS died.

Males

Parameter	HR [95% CI]	p-value
F5_CANNABIS	7.831 [6.98, 8.79]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 971 out of 9587 males with F5_CANNABIS died.

Mortality risk

Mortality risk for people of age

years, who have F5_CANNABIS.

N-year risk	Females	Males
1	1.23%	1.34%
5	7.057%	8.863%
10	15.849%	21.207%
15	28.471%	35.437%
20	45.872%	53.733%

Relationships between endpoints

↥

Index endpoint: F5_CANNABIS – Mental and behavioural disorders due to cannabinoids

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mental and behavioural disorders due to cannabinoids

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints